Mallinckrodt posts $4.19 million operating loss for January period

By Sarah Lizee

Olympia, Wash., Feb. 22 – Mallinckrodt plc reported a $4.19 million operating loss on zero net sales for the period of Dec. 26 through Jan. 22, according to its monthly operating report filed Monday with the U.S. Bankruptcy Court for the District of Delaware.

For comparison, the company posted $5.79 million operating income on zero net sales for the period of Nov. 28 through Dec. 25.

The net loss for January was $4.29 million, compared to a $2.85 million net income for the December period.

The company listed $2.24 million of cash and cash equivalents as of Jan. 22, compared to $2.53 million as of Dec. 25.

Dublin-based Mallinckrodt develops, manufactures, markets and distributes specialty pharmaceutical products and therapies. The company filed Chapter 11 bankruptcy on Oct. 12 under case number 20-12522.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.